Get started
Author

Alex Stubbing-Moore

Vitreoretinal interface abnormalities in patients treatedwith ranibizumab for diabetic macular oedema
2016 · The Sunderland Eye Infirmary study group, Yun Wong, et al. · Graefe s Archive for Clinical and Experimental Ophthalmology · 50
PDF
Foveal Hypoplasia Grading with Optical Coherence Tomography: Agreement and Challenges Across Experience Levels
2025 · Riddhi Shenoy, Gail D. E. Maconachie, et al. · Diagnostics · 1
Real life experience of combined fixed-dosing and Treat and Extend protocols for the treatment of Diabetic Macular Oedema (DMO) with Anti-Vascular Endothelial Growth Factors (VEGF) agents
2017 · Karim El-Assal, Alex Stubbing-Moore, et al. · Investigative Ophthalmology & Visual Science · 1
Anatomical and Functional Outcomes of Repeat Vitrectomy Combined with Encircling Scleral Buckling for First Recurrent Rhegmatogenous Retinal Detachment After Primary Vitrectomy: A Retrospective Cohort Study
2026 · Georgios D. Panos, Alex Stubbing-Moore, et al. · Journal of Clinical Medicine
Perineural Invasion of Occult Cutaneous Squamous Cell Carcinoma Mimicking Tolosa-Hunt Syndrome
2024 · Alex Stubbing-Moore, Hussein Uraiby, et al. · Neuro-Ophthalmology
PDF
Vitreoretinal interface abnormalities in patients treated with ranibizumab for diabetic macular oedema
2017 · Y Wong, David Steel, et al. · Newcastle University ePrints (Newcastle Univesity)
Are the initial treatment results of Ranibizumab for Diabetic Macular Oedema maintained at 1 year with Pro re nata protocol? A real life experience.
2016 · Ajay Kotagiri, Maged Habib, et al. · Investigative Ophthalmology & Visual Science
Works count: 7
Citation count: 52
H-index: 1
I10-index: 1
Year
Topic
Type